HWMA
BCRX icon

Heritage Wealth Management (Arizona)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Heritage Wealth Management (Arizona)’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$574 Buy
50
+25
+100% +$312 ﹤0.01% 1047
2022
Q3 		$0 Hold
25
– – ﹤0.01% 1010
2022
Q2 		$265 Hold
25
– – ﹤0.01% 964
2022
Q1 		$0 Buy
+25
New +$401 ﹤0.01% 975

Other funds holding BCRX

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return

Heritage Wealth Management (Arizona)'s BCRX Position: Q4 2022 in Review

Heritage Wealth Management (Arizona) increased its BioCryst Pharmaceuticals (BCRX) stake by 100% in Q4 2022, buying an estimated $312 and bringing the position to 50 shares worth $574. The position accounts for ﹤0.01% of the portfolio, ranked #1047.

Heritage Wealth Management (Arizona) first reported a position in BCRX in Q1 2022 and has held it in 4 quarters since. 230 funds tracked by Wall St. Rank hold BCRX as of Q4 2022.

  • Heritage Wealth Management (Arizona) held 50 shares of BioCryst Pharmaceuticals worth $574 as of Q4 2022.
  • Heritage Wealth Management (Arizona) bought 25 BioCryst Pharmaceuticals shares in Q4 2022, an estimated $312.
  • BioCryst Pharmaceuticals made up ﹤0.01% of Heritage Wealth Management (Arizona)'s portfolio in Q4 2022, its #1047 holding.
  • Heritage Wealth Management (Arizona) first reported a position in BioCryst Pharmaceuticals in Q1 2022 and has held it in 4 quarters since.
  • 230 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q4 2022.

Based on Heritage Wealth Management (Arizona)'s 13F filing for Q4 2022, filed 13 Feb 2023.